Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2

被引：27
作者：
Shahrajabian, Mohamad Hesam [1 ]
Sun, Wenli [1 ]
Cheng, Qi [1 ,2 ,3 ]
机构：
[1] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China
[2] Hebei Agr Univ, Coll Life Sci, Baoding, Hebei, Peoples R China
[3] Global Alliance HeBAU CLS & HeQiS BioAl Mfg, Baoding, Hebei, Peoples R China
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2021年 / 17卷 / 01期
关键词：
SARS; coronaviruses; SARS-CoV-2; MERS; pneumonia; emerging diseases; RESPIRATORY SYNDROME-CORONAVIRUS; RECEPTOR-BINDING DOMAIN; DIPEPTIDYL PEPTIDASE 4; ELICITS HIGH TITERS; SPIKE PROTEIN; 2019; COVID-19; IN-VITRO; IMMUNE-RESPONSES; SAUDI-ARABIA; FUNCTIONAL-CHARACTERIZATION;
D O I：
10.1080/21645515.2020.1797369
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
SARS-CoV-2, the virus causing COVID-19, is a single-stranded RNA virus belonging to the order Nidovirales, family Coronaviridae, and subfamily Coronavirinae. SARS-CoV-2 entry to cellsis initiated by the binding of the viral spike protein (S) to its cellular receptor. The roles of S protein in receptor binding and membrane fusion makes it a prominent target for vaccine development. SARS-CoV-2 genome sequence analysis has shown that this virus belongs to the beta-coronavirus genus, which includes Bat SARS-like coronavirus, SARS-CoV and MERS-CoV. A vaccine should induce a balanced immune response to elicit protective immunity. In this review, we compare and contrast these three important CoV diseases and how they inform on vaccine development.
引用
收藏
页码：62 / 83
页数：22
相关论文
共 348 条
[81]   Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice [J].
DeDiego, Marta L. ;
Pewe, Lecia ;
Alvarez, Enrique ;
Rejas, Maria Teresa ;
Perlman, Stanley ;
Enjuanes, Luis .
VIROLOGY, 2008, 376 (02) :379-389
[82]   A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo [J].
DeDiego, Marta L. ;
Alvarez, Enrique ;
Almazan, Fernando ;
Rejas, Maria Teresa ;
Lamirande, Elaine ;
Roberts, Anjeanette ;
Shieh, Wun-Ju ;
Zaki, Sherif R. ;
Subbarao, Kanta ;
Enjuanes, Luis .
JOURNAL OF VIROLOGY, 2007, 81 (04) :1701-1713
[83]   Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Regulates Cell Stress Response and Apoptosis [J].
DeDiego, Marta L. ;
Nieto-Torres, Jose L. ;
Jimenez-Guardeno, Jose M. ;
Regla-Nava, Jose A. ;
Alvarez, Enrique ;
Carlos Oliveros, Juan ;
Zhao, Jincun ;
Fett, Craig ;
Perlman, Stanley ;
Enjuanes, Luis .
PLOS PATHOGENS, 2011, 7 (10)
[84]  
Demmler Gail J, 2003, Semin Pediatr Infect Dis, V14, P240
[85]   Protecting healthcare staff from severe acute respiratory syndrome: filtration capacity of multiple surgical masks [J].
Derrick, JL ;
Gomersall, CD .
JOURNAL OF HOSPITAL INFECTION, 2005, 59 (04) :365-368
[86]  
Dhama K., 2014, Asian Journal of Animal and Veterinary Advances, V9, P164, DOI 10.3923/ajava.2014.164.176
[87]   A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination [J].
Dighe, Amy ;
Jombart, Thibaut ;
Van Kerkhove, Maria D. ;
Ferguson, Neil .
EPIDEMICS, 2019, 29
[88]   Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways [J].
Ding, YQ ;
He, L ;
Zhang, QL ;
Huang, ZX ;
Che, XY ;
Hou, JL ;
Wang, HJ ;
Shen, H ;
Qiu, LW ;
Li, ZG ;
Geng, J ;
Cai, JJ ;
Han, HX ;
Li, X ;
Kang, W ;
Weng, DS ;
Liang, P ;
Jiang, SB .
JOURNAL OF PATHOLOGY, 2004, 203 (02) :622-630
[89]  
Dolan Susan A, 2003, J Spec Pediatr Nurs, V8, P75, DOI 10.1111/j.1744-6155.2003.tb00190.x
[90]   Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease [J].
Douglas, Madeline G. ;
Kocher, Jacob F. ;
Scobey, Trevor ;
Baric, Ralph S. ;
Cockrell, Adam S. .
VIROLOGY, 2018, 517 :98-107
45678910111213